AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Medical Decision Making in Multiple System Atrophy

RecruitingNAAges 30 Years - anyAllMedical University Innsbruck
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical study is to evaluate the effects of a personalized symptomatic treatment plan integrated with monthly telemedicine and mobile palliative care interventions on a population of individuals diagnosed with Multiple System Atrophy (MSA) and their informal caregivers. The aim is to improve the quality of life of MSA patients and their caregivers, as well as provide them with better support during the disease progression. After a baseline visit, all 46 patients will receive a personalized therapeutic plan (including medical treatment, physiotherapy, logotherapy and occupational therapy excercises and psychological support) and contact with social workers and a palliative care team. They willl then be re-evaluated at 6-,12-, 18- month visits. Semi-structured online interviews at baseline and 12 month visit will collect patients' individual healthcare preferences, which

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria For individuals with MSA: * Age โ‰ฅ30 years at the time of consent; * Diagnosed with clinically probable or clinically established MSA according to the current MDS MSA criteria (1); * Life-expectancy of at least 24 months as assessed by the investigator at the time of consent; * Understands and agrees to comply with the study procedures and provides written informed consent (Note: a legal representative may NOT provide consent on behalf of the subject); * Signed and dated informed consent document; * Fluency in German; * If not able to walk or stand without assistance/support at the time of consent, the participant lives in Tyrol or in another Austrian Region with available mobile palliative care. For informal caregivers: * Informal caregiver (i.e. person not receiving payment for his/her caregiving) of an individual with MSA recruited in the present study; * Life-expectancy of at least 24 months as assessed by the investigator at the time of consent; * Ageโ‰ฅ 18 years at the time of consent; * Understands and agrees to provide information as outlined in the study protocol and to engage in semi-structured online interviews; * Provides signed and dated written informed consent; * Full legal capacity; * Fluency in German. Exclusion Criteria For individuals with MSA * Participation in an interventional clinical study at screening and throughout the study that would interfere with the MeDeMSA Care personalized treatment plan or would not permit telemedicine and mobile palliative care strategies; * Charlson comorbidity index \>4 at the time of consent; * Other major underlying medical conditions that may confound interpretation of study results as assessed by the investigator.
๐Ÿ’Š

What it tests

  • Telemedicine visits
  • Multidisciplinary, personalized symptomatic treatment
๐Ÿ“

Where

1 site
Innsbruck Medical University
Innsbruck, Austria
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy